Recent Comments

    Social menu is not set. You need to create menu and assign it to Social Menu on Menu Settings.


    1 min read

    National Democratic Alliance (NDA) candidate Vijay Sinha was on Wednesday elected as Bihar Assembly Speaker with 126 MLAs voting in favour as against 114 votes...

    1 min read

    Delhi-NCR and the threat of second wave in Punjab, Chief Minister Captain Amarinder Singh on Wednesday directed to impose several new restrictions in the state....

    1 min read

    An investment of Rs 6,000 crore in the National Investment and Infrastructure Fund (NIIF) was approved by the Cabinet on Wednesday. This amount will be invested...

    1 min read

    Cyclone Nivar is likely to cross between Mamallapuram and Karaikal during midnight of Wednesday and early hours of November 26, as per India Meteorological Department...

    1 min read

    Equity benchmark indices opened in the green on Wednesday with Sensex up by 277.40 points and Nifty up by 84.85 points. The domestic stock markets...

    November 25, 2020

    COVID-19 vaccine distribution: PM Modi reviews preparation

    1 min read


    Prime Minister Narendra Modi on Friday reviewed India’s preparations for vaccinating its vast population against the coronavirus disease, once a vaccine becomes available. Vaccination must be affordable and universal, Modi said. "Important issues related to progress of vaccine development, regulatory approvals and procurement were discussed," Modi wrote on Twitter.

    "Reviewed various issues like prioritisation of population groups, reaching out to healthcare workers, cold-chain Infrastructure augmentation, adding vaccinators, and tech platform for vaccine roll-out, the prime minister added.

    Five vaccine candidates are at the different stages of trials in India. Covaxin by Bharat Biotech and Covishield, developed by the University of Oxford have already started the phase III clinical trial. ZyCoV-D by Zydus Cadila is in the phase II clinical trial in the country. Dr Reddy's Laboratories will soon start phase II clinical trials of the Russian COVID-19 vaccine Sputnik V in India.

    India’s experience in conducting elections and handling disaster management should be put to use in managing COVID-19 vaccine delivery and administration and experts in all necessary domains, officials at all levels, Modi said earlier.

    The Prime Minister further directed that keeping in view the geographical span and diversity of the country, the access to the vaccine should be ensured speedily, the statement mentioned.

    Leave a Reply

    Your email address will not be published. Required fields are marked *